These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 12184360)

  • 1. Aluminum salts in vaccines--US perspective.
    Baylor NW; Egan W; Richman P
    Vaccine; 2002 May; 20 Suppl 3():S18-23. PubMed ID: 12184360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global impact of vaccines containing aluminium adjuvants.
    Clements CJ; Griffiths E
    Vaccine; 2002 May; 20 Suppl 3():S24-33. PubMed ID: 12184361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.
    Mark A; Björkstén B; Granström M
    Vaccine; 1995 May; 13(7):669-73. PubMed ID: 7668036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium phosphate: a substitute for aluminum adjuvants?
    Masson JD; Thibaudon M; Bélec L; Crépeaux G
    Expert Rev Vaccines; 2017 Mar; 16(3):289-299. PubMed ID: 27690701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of consistent relationship between quantity of aluminum in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions.
    Rennels MB; Deloria MA; Pichichero ME; Englund JA; Anderson EL; Steinhoff MC; Decker MD; Edwards KM
    Vaccine; 2002 May; 20 Suppl 3():S44-7. PubMed ID: 12184364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence.
    Jefferson T; Rudin M; Di Pietrantonj C
    Lancet Infect Dis; 2004 Feb; 4(2):84-90. PubMed ID: 14871632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine.
    Gupta RK; Relyveld EH
    Vaccine; 1991 Oct; 9(10):699-702. PubMed ID: 1759487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aluminium adjuvant exposure through vaccines in France in 2018].
    Angrand L; Elnar AA; Authier FJ; Gherardi RK; Crépeaux G
    Ann Pharm Fr; 2020 Mar; 78(2):111-128. PubMed ID: 32081303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aluminum content of biological products containing aluminum adjuvants: determination by atomic absorption spectrometry.
    May JC; Progar JJ; Chin R
    J Biol Stand; 1984; 12(2):175-83. PubMed ID: 6736048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.
    Aggerbeck H; Heron I
    Vaccine; 1995 Oct; 13(14):1360-5. PubMed ID: 8585294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workshop summary. Aluminum in vaccines.
    Eickhoff TC; Myers M
    Vaccine; 2002 May; 20 Suppl 3():S1-4. PubMed ID: 12184358
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvants for vaccines to drugs of abuse and addiction.
    Alving CR; Matyas GR; Torres O; Jalah R; Beck Z
    Vaccine; 2014 Sep; 32(42):5382-9. PubMed ID: 25111169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b-CRM197 conjugate vaccine.
    Kanra G; Viviani S; Yurdakök K; Ozmert E; Anemona A; Yalçin S; Demiralp O; Bilgili N; Kara A; Cengiz AB; Mutlu B; Baldini A; Marchetti E; Podda A
    Pediatr Int; 2003 Jun; 45(3):314-8. PubMed ID: 12828588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the effect of Al(OH)3 as an immunological adjuvant.
    Majgaard Jensen O; Koch C
    APMIS; 1988 Mar; 96(3):257-64. PubMed ID: 3348913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aluminum as an adjuvant in vaccines and post-vaccine reactions].
    Fiejka M; Aleksandrowicz J
    Rocz Panstw Zakl Hig; 1993; 44(1):73-80. PubMed ID: 8235346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adjuvants on the immunogenicity of Habu-venom toxoid in the monkey and the guinea pig.
    Sadahiro S; Kondo S; Yamamoto A
    Jpn J Med Sci Biol; 1981 Jun; 34(3):169-73. PubMed ID: 6796732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III.
    Aggerbeck H; Wantzin J; Heron I
    Vaccine; 1996 Sep; 14(13):1265-72. PubMed ID: 8961516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A need for effective adjuvants.
    Bunce CJ; Morse MA
    Curr Opin Mol Ther; 2003 Feb; 5(1):8-9. PubMed ID: 12669464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.